DNTH

Dianthus Therapeutics, Inc. DNTH

Individual Beneficiary

Name of reporting person Citizenship or organization Sole voting power Shared voting power Sole dispositive power Shared dispositive power Amount beneficially owned Percent of class Accepted date
TCG Crossover GP II, LLC Delaware 0 1501624 0 1501624 1501624 5.1 % 22/11/2024
Chen Yu United States of America 0 1501624 0 1501624 1501624 5.1 % 22/11/2024
TCG Crossover Fund II, L.P. Delaware 0 1501624 0 1501624 1501624 5.1 % 22/11/2024
Venrock Healthcare Capital Partners EG, L.P. Delaware 0 1744373 0 1744373 1744373 5.9 % 14/11/2024
VHCP Holdings III, LLC Delaware 0 1744373 0 1744373 1744373 5.9 % 14/11/2024
VHCP Management III, LLC Delaware 0 1744373 0 1744373 1744373 5.9 % 14/11/2024
VHCP Management EG, LLC Delaware 0 1744373 0 1744373 1744373 5.9 % 14/11/2024
Shah, Nimish United States 0 1744373 0 1744373 1744373 5.9 % 14/11/2024
Koh, Bong United States 0 1744373 0 1744373 1744373 5.9 % 14/11/2024
Venrock Healthcare Capital Partners III, L.P. Delaware 0 1744373 0 1744373 1744373 5.9 % 14/11/2024
BlackRock, Inc. Delaware 0 0 1644819 0 1644819 5.6 % 24/10/2024
Ting Jia China 0 1746667 0 1746667 1746667 6 % 11/10/2024
Octagon Private Opportunities Fund II LP Delaware 0 291667 0 291667 291667 1 % 11/10/2024
Octagon Capital Advisors LP Delaware 0 1746667 0 1746667 1746667 6 % 11/10/2024
Octagon Investments Master Fund LP Cayman Islands 0 1455000 0 1455000 1455000 5 % 11/10/2024

Senat trading

Bureau Date de la transaction Date de réception Type Amount Commentaire

Senat Divulgation

Représentant Date de la transaction Date de divulgation Type Amount District